SALUBRIS

Serial Number 88133406
Registration 5952886
700

Registration Progress

Application Filed
Sep 26, 2018
Under Examination
Approved for Publication
Oct 22, 2019
Published for Opposition
Oct 22, 2019
Registered
Jan 7, 2020

Trademark Image

SALUBRIS

Basic Information

Serial Number
88133406
Registration Number
5952886
Filing Date
September 26, 2018
Registration Date
January 7, 2020
Published for Opposition
October 22, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 7, 2020
Registration
Registered
Classes
005

Rights Holder

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

99
Address
37F, Main Tower, Lvjing plaza
Che Gong Miao,No.6009,Shennan Rd, Futian
Shenzhen, Guangdong Pr 518040
CN

Ownership History

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

Original Applicant
99
Shenzhen, Guangdong Pr CN

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

Owner at Publication
99
Shenzhen, Guangdong Pr CN

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

Original Registrant
99
Shenzhen, Guangdong Pr CN

Legal Representation

Attorney
Timothy T. Wang

Application History

31 events
Date Code Type Description Documents
Jan 7, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 7, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 22, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 22, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 2, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 18, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 9, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 9, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 9, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 9, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 7, 2019 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Aug 6, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 6, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 6, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 6, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 5, 2019 ALIE A ASSIGNED TO LIE Loading...
Jul 31, 2019 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jul 30, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 30, 2019 PETG O PETITION TO REVIVE-GRANTED Loading...
Jul 30, 2019 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Jul 29, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 29, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 10, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 17, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 17, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 17, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 16, 2019 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Jan 16, 2019 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jan 8, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 4, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 29, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system; Pharmaceutical preparations for use in treating cancerous tumors; Pharmaceutical preparations for use in treating metabolic diseases and diseases of the immune system and the musculo-skeletal system; Chemical preparations for pharmaceutical or medical purposes, namely, Pharmaceutical preparations for use in haematology, dermatology, ophthalmology and gastroenterology, Pharmaceutical preparations being anti-infectives, Pharmaceutical preparations for use in treating diseases of the respiratory system, the digestive system, and the endocrine system, Pharmaceutical preparations for use in treating hypersensitivity diseases; Medicines for human purpose for treating disease, namely, pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system, pharmaceutical preparations for use in treating cancerous tumors, pharmaceutical preparations for use in treating metabolic diseases, as well as diseases of the immune system and the musculo-skeletal system; Active pharmaceutical ingredients in the nature of pharmaceutical preparations used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, and the musculo-skeletal system, and for treating cancerous tumors; Biochemical medicines for use in treating diseases of the cardiovascular system and cerebrovascular system; Biochemical medicines for use in treating cancerous tumors; Biochemical medicines for use in treating metabolic diseases, nervous system diseases as well as diseases of the immune system and the musculo-skeletal system; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the metabolic system, the respiratory system, and the musculo-skeletal system, pharmaceutical preparations for use in tissue and organ transplantation, for use in ophthalmology and for use in treatment of gastroenterological disorders

Classification

International Classes
005